ORLANDI, ELENA
ORLANDI, ELENA
Dipartimento di Medicina Molecolare e Traslazionale
Current management and future challenges in salivary glands cancer
2023-01-01 Locati, L. D.; Ferrarotto, R.; Licitra, L.; Benazzo, M.; Preda, L.; Farina, D.; Gatta, G.; Lombardi, D.; Nicolai, P.; Vander Poorten, V.; Chua, M. L. K.; Vischioni, B.; Sanguineti, G.; Morbini, P.; Fonseca, I.; Sozzi, D.; Merlotti, A.; Orlandi, E.
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement
2016-01-01 Buglione, M.; Cavagnini, R.; Di Rosario, F.; Maddalo, M.; Vassalli, L.; Grisanti, S.; Salgarello, S.; Orlandi, E.; Bossi, P.; Majorana, A.; Gastaldi, G.; Berruti, A.; Trippa, F.; Nicolai, P.; Barasch, A.; Russi, E. G.; Raber-Durlacher, J.; Murphy, B.; Magrini, S. M.
Patient selection for immunotherapy in head and neck cancer
2021-01-01 Bonomo, P.; Orlandi, E.; Bossi, P.
Preemptive treatment with Xonrid®, a medical device to reduce radiation induced dermatitis in head and neck cancer patients receiving curative treatment: a pilot study
2017-01-01 Iacovelli, N. A.; Naimo, S.; Bonfantini, F.; Cavallo, A.; Bossi, P.; Fallai, C.; Pignoli, E.; Alfieri, S.; Bergamini, C.; Favales, F.; Orlandi, E.
Prognostic role of PIK3CA and TP53 in human papillomavirus–negative oropharyngeal cancers
2018-01-01 Resteghini, C.; Perrone, F.; Miceli, R.; Bergamini, C.; Alfieri, S.; Orlandi, E.; Guzzo, M.; Granata, R.; Galbiati, D.; Cavalieri, S.; Locati, L.; Licitra, L.; Bossi, P.
Resection of the internal carotid artery in selected patients affected by cancer of the skull base
2022-01-01 Ferrari, M.; Zanoletti, E.; Taboni, S.; Cazzador, D.; Tealdo, G.; Schreiber, A.; Mattavelli, D.; Rampinelli, V.; Doglietto, F.; Fontanella, M. M.; Buffoli, B.; Vural, A.; Verzeletti, V.; Carobbio, A. L. C.; Mardighian, D.; Causin, F.; Orlandi, E.; Cenzato, M.; Rezzani, R.; Nicolai, P.
Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy
2019-01-01 Alessi, A.; Lorenzoni, A.; Cavallo, A.; Padovano, B.; Iacovelli, N. A.; Bossi, P.; Alfieri, S.; Serafini, G.; Colombo, C. B.; Cicchetti, A.; Mira, M.; Licitra, L.; Fallai, C.; Crippa, F.; Orlandi, E.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Current management and future challenges in salivary glands cancer | 1-gen-2023 | Locati, L. D.; Ferrarotto, R.; Licitra, L.; Benazzo, M.; Preda, L.; Farina, D.; Gatta, G.; Lombardi, D.; Nicolai, P.; Vander Poorten, V.; Chua, M. L. K.; Vischioni, B.; Sanguineti, G.; Morbini, P.; Fonseca, I.; Sozzi, D.; Merlotti, A.; Orlandi, E. | |
| Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement | 1-gen-2016 | Buglione, M.; Cavagnini, R.; Di Rosario, F.; Maddalo, M.; Vassalli, L.; Grisanti, S.; Salgarello, S.; Orlandi, E.; Bossi, P.; Majorana, A.; Gastaldi, G.; Berruti, A.; Trippa, F.; Nicolai, P.; Barasch, A.; Russi, E. G.; Raber-Durlacher, J.; Murphy, B.; Magrini, S. M. | |
| Patient selection for immunotherapy in head and neck cancer | 1-gen-2021 | Bonomo, P.; Orlandi, E.; Bossi, P. | |
| Preemptive treatment with Xonrid®, a medical device to reduce radiation induced dermatitis in head and neck cancer patients receiving curative treatment: a pilot study | 1-gen-2017 | Iacovelli, N. A.; Naimo, S.; Bonfantini, F.; Cavallo, A.; Bossi, P.; Fallai, C.; Pignoli, E.; Alfieri, S.; Bergamini, C.; Favales, F.; Orlandi, E. | |
| Prognostic role of PIK3CA and TP53 in human papillomavirus–negative oropharyngeal cancers | 1-gen-2018 | Resteghini, C.; Perrone, F.; Miceli, R.; Bergamini, C.; Alfieri, S.; Orlandi, E.; Guzzo, M.; Granata, R.; Galbiati, D.; Cavalieri, S.; Locati, L.; Licitra, L.; Bossi, P. | |
| Resection of the internal carotid artery in selected patients affected by cancer of the skull base | 1-gen-2022 | Ferrari, M.; Zanoletti, E.; Taboni, S.; Cazzador, D.; Tealdo, G.; Schreiber, A.; Mattavelli, D.; Rampinelli, V.; Doglietto, F.; Fontanella, M. M.; Buffoli, B.; Vural, A.; Verzeletti, V.; Carobbio, A. L. C.; Mardighian, D.; Causin, F.; Orlandi, E.; Cenzato, M.; Rezzani, R.; Nicolai, P. | |
| Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy | 1-gen-2019 | Alessi, A.; Lorenzoni, A.; Cavallo, A.; Padovano, B.; Iacovelli, N. A.; Bossi, P.; Alfieri, S.; Serafini, G.; Colombo, C. B.; Cicchetti, A.; Mira, M.; Licitra, L.; Fallai, C.; Crippa, F.; Orlandi, E. |